May 4 / Lívea Coda

Remapping global sugar demand: what has changed?

  • Global sugar demand growth is becoming increasingly structural, driven by demographic trends and income growth rather than cyclical dynamics.
  • Emerging economies – particularly in Asia and Africa - are expected to account for the bulk of future consumption gains, according to FAO.
  • Developed markets are likely to see slower growth amid rising health concerns and regulatory pressures.
  • Sugar-sweetened beverage (SSB) taxes curb local beverage consumption, but their impact on aggregate sugar demand remains uncertain and uneven across countries.
  • Overall, population and income growth continue to outweigh policy and lifestyle headwinds as the dominant long‑term demand drivers.

Remapping global sugar demand: what has changed?

Global sugar consumption dynamics are undergoing a gradual yet structural transformation, increasingly shaped by long‑term demographic trends, income growth, and evolving policy frameworks rather than short‑term cyclical forces. While global demand continues to expand, growth is becoming increasingly concentrated in emerging economies, where population growth and rising living standards still create room for further consumption gains. In contrast, mature markets face structurally weaker demand, reflecting demographic stagnation, shifting consumer preferences, and intensifying health‑related policy interventions.


In this report, we assess the key drivers behind sugar consumption growth and examine the long-term trends reshaping global demand. 
For instance, the FAO projects global sugar consumption to grow at around 1.2% per year, reaching approximately 202 Mt by 2034. According to the agency, this expansion is primarily driven by demographic trends and income growth rather than cyclical factors. From a pricing perspective, this demand trajectory provides underlying support - particularly in scenarios where supply growth falls short of expectations.


Demand growth is expected to be concentrated in low- and middle-income regions, mainly across Asia and Africa, which together are projected to account for roughly 93% of net global consumption gains. Rapid population growth, accelerating urbanization, and income-driven dietary shifts are the key drivers behind this trend. Given the still low per capita consumption levels in many of these countries, sugar demand growth remains far from saturation, according to the agency.

Conversely, high‑income economies are expected to exhibit structurally weak demand growth, acting as a bearish counterweight – though not a dominant one. In developed markets, slower population growth and evolving consumer preferences, reinforced by health concerns and public policy measures, are likely to keep sugar consumption broadly flat or on a mild downward trajectory. This trend is largely anticipated by the market and, therefore, has already been priced in, limiting its downside impact on prices.


Consumption dynamics are thus closely tied to income and population growth. As illustrated by the GDP (Purchasing Power Parity) versus per capita consumption relationship, sugar intake increases rapidly at lower income levels but gradually flattens as countries reach higher GDP thresholds, where demand becomes increasingly inelastic to further income gains. This saturation effect is evident in developed economies, where consumption trends remain broadly stable despite higher income levels, while emerging economies continue to exhibit significant catch‑up potential.


10-year Consumption: Per Capita Sugar Consumption versus GDP (PPP)

Source: IMF, Green Pool, Hedgepoint


However, inflationary pressures have already weighed on demand in some key markets - most notably India, which is expected to record a second consecutive year of consumption contraction. In addition, countries facing stagnant or declining populations continue to exert downward pressure on global consumption growth.

As a result, global sugar demand growth is estimated at just 0.4% in 2025/26 (Oct–Sep), diverging from the FAO’s projections. Looking ahead, demand growth is expected to recover only modestly, averaging around 0.77% in both the 2026/27 and 2027/28 seasons.

Another factor contributing to the deceleration in sugar consumption, in our analysis, stems from government-led tax and regulatory measures. While their effects are difficult to quantify precisely, most countries that have introduced restrictions have relied on mandatory product labelling and, more commonly, taxes on sugar sweetened beverages (SSBs). These policies are driven by the well-documented links between SSB consumption and major health concerns, such as obesity and related diseases, which raise public healthcare costs, as well as growing concerns over the addictive nature of these products.

The World Bank tracks the global implementation of SSB taxes and currently reports 119 national level taxes across 117 countries, covering roughly 57% of the world’s population. There is robust empirical evidence indicating that SSB taxation leads to lower consumption of these beverages. Mexico offers a clear example: as the first country in the Americas to adopt an SSB tax in 2014, empirical studies indicate a 6.3% decline in observed SSB purchases relative to expected levels, with a more pronounced reduction among low income households - reflecting their higher price elasticity (Colchero et al., 2017).


National-level excise taxes on sugar-sweetened beverages (July 2024)

Source: World Health Organization, 2025


While no study explicitly quantifies the direct pass-through from reduced SSB consumption to aggregate national sugar intake, the relationship is intuitive: the higher the levy, the stronger the impact on consumption. Direct taxes on sugar itself do exist but remain extremely rare. Finland and Norway are among the few examples, having implemented product‑based taxes – most notably Norway, which taxes categories such as sugar, chocolate, confectionery, and sweets.


Nevertheless, when assessing the impact of SSB taxes on overall sugar consumption at the country level, no clear or consistent pattern emerges. In some cases, such as Mexico and Chile, an immediate deceleration in sugar consumption is observed following the introduction of the tax. In others, however - including Thailand and the UAE - similar effects are not easily identifiable, suggesting that the transmission from beverage taxes to aggregate sugar demand remains heterogeneous and context-dependent.

Tax imposition versus Consumption, Population Growth and GDP Growth

Source: IMF, USDA, Hedgepoint


While differences in tax design, coverage and enforcement undoubtedly matter, the lack of a consistent consumption response across countries suggests that the impact of SSB taxes on aggregate sugar demand is far from straightforward. This dispersion indicates that other structural forces exert a stronger influence on consumption trends. For instance, USDA data show that sugar consumption in Thailand has risen sharply in recent years – development that appears more closely linked to GDP growth and rising incomes than to the introduction of SSB taxation.

Another widely discussed theme in the sugar market - though one that still lacks robust empirical validation - is the rapid uptake of injectable medications targeting the glucagon like peptide 1 (GLP 1) receptor and the glucose dependent insulinotropic polypeptide (GIP) receptor. These therapies act through multiple channels, including delayed gastric emptying, reduced hepatic glucose production, attenuation of post meal glucose spikes, increased insulin secretion, and central appetite suppression. Tirzepatide, in particular, has been associated with significant weight loss. However, evidence linking these treatments to a systematic shift away from high fat or high sugar foods remains limited and preliminary (e.g., Martin et al., 2025; Kennedy et al., 2015). To date, no studies quantify their potential impact on aggregate sugar consumption or broader population-level dietary patterns.

Moreover, even if future research were to confirm systematic changes in food preferences among users of these therapies, important structural constraints would remain. Access and affordability raise key questions regarding adoption rates and scalability across the general population. As a result, extrapolating the effects of these medications to national sugar consumption trends remains premature at this stage.
In conclusion, while these developments warrant close monitoring, there is currently no evidence of measurable impact on country-level sugar consumption. Looking ahead, we continue to expect income and population growth to remain the dominant drivers of global sugar demand.

Weekly Report — Sugar

Written by Lívea Coda
livea.coda@hedgepointglobal.com


Reviewed by Thaís Italiani
thais.italiani@hedgepointglobal.com

Disclaimer

This document has been prepared by Hedgepoint Schweiz AG and its affiliates (“Hedgepoint”) solely for informational and instructional purposes, without intending to create obligations or commitments to third parties. It is not intended to promote or solicit an offer for the sale or purchase of any securities, commodities interests, or investment products.

Hedgepoint and its associates expressly disclaim any liability for the use of the information contained herein that directly or indirectly results in any kind of damages. Information is obtained from sources which we believe to be reliable, but we do not warrant or guarantee the timeliness or accuracy of this information.
The trading of commodities interests, such as futures, options, and swaps, involves substantial risk of loss and may not be suitable for all investors. You should carefully consider wither such trading is suitable for you in light of your financial condition. Past performance is not necessarily indicative of future results. Customers should rely on their own independent judgment and/or consult advisors before entering into any transactions.
Hedgepoint does not provide legal, tax or accounting advice and you are responsible for seeking any such advice separately.
Hedgepoint Schweiz AG is organized, incorporated, and existing under the laws of Switzerland, is filiated to ARIF, the Association Romande des Intermédiaires Financiers, which is a FINMA-authorized Self-Regulatory Organization. Hedgepoint Commodities LLC is organized, incorporated, and existing under the laws of the USA, and is authorized and regulated by the Commodity Futures Trading Commission (CFTC) and a member of the National Futures Association (NFA) to act as an Introducing Broker and Commodity Trading Advisor. HedgePoint Global Markets Limited is Regulated by the Dubai Financial Services Authority. The content is directed at Professional Clients and not Retail Clients. Hedgepoint Global Markets PTE. Ltd is organized, incorporated, and existing under the laws of Singapore, exempted from obtaining a financial services license as per the Second Schedule of the Securities and Futures (Licensing and Conduct of Business) Act, by the Monetary Authority of Singapore (MAS). Hedgepoint Global Markets DTVM Ltda. is authorized and regulated in Brazil by the Central Bank of Brazil (BCB) and the Brazilian Securities Commission (CVM). Hedgepoint Serviços Ltda. is organized, incorporated, and existing under the laws of Brazil. Hedgepoint Global Markets S.A. is organized, incorporated, and existing under the laws of Uruguay. In case of questions not resolved by the first instance of customer contact (client.services@Hedgepointglobal.com), please contact internal ombudsman channel (ombudsman@hedgepointglobal.com – global or ouvidoria@hedgepointglobal.com – Brazil only) or call 0800-8788408 (Brazil only).
Integrity, ethics, and transparency are values that guide our culture. To further strengthen our practices, Hedgepoint has a whistleblower channel for employees and third-parties by e-mail ethicline@hedgepointglobal.com or forms Ethic Line – Hedgepoint Global Markets.
“HedgePoint” and the “HedgePoint” logo are marks for the exclusive use of HedgePoint and/or its affiliates. Use or reproduction is prohibited, unless expressly authorized by HedgePoint.
Furthermore, the use of any other marks in this document has been authorized for identification purposes only. It does not, therefore, imply any rights of HedgePoint in these marks or imply endorsement, association or seal by the owners of these marks with HedgePoint or its affiliates.

To access this report, you need to be a subscriber.